Next report date
Report period
Q2 2024
EPS estimate
—
Revenue estimate
—
0.24CNY
95.58 MCNY
454.38 MCNY
95.57 M
About SHANGHAI SANYOU MEDICAL
Sector
Industry
CEO
Nong Xu
Website
Headquarters
Shanghai
Employees (FY)
466
Founded
2005
ISIN
CNE1000040J7
FIGI
BBG00PKT6CK3
Shanghai Sanyou Medical Co. Ltd. principally engages in the research, development, production, and sale of medical orthopedic implant consumables. The company was founded by Min Yan Liu, Nong Xu and Xiang Long Fan on April 19, 2005 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688085 is 18.80 CNY — it has increased by 3.01% in the past 24 hours. Watch SHANGHAI SANYOU MEDICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI SANYOU MEDICAL stocks are traded under the ticker 688085.
SHANGHAI SANYOU MEDICAL is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
688085 stock is 4.48% volatile and has beta coefficient of 1.20. Track SHANGHAI SANYOU MEDICAL stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI SANYOU MEDICAL there?
SHANGHAI SANYOU MEDICAL revenue for the last quarter amounts to 118.09 M CNY despite the estimated figure of 118.19 M CNY. In the next quarter revenue is expected to reach 129.51 M CNY.
Yes, you can track SHANGHAI SANYOU MEDICAL financials in yearly and quarterly reports right on TradingView.
688085 stock has risen by 6.09% compared to the previous week, the month change is a 23.77% rise, over the last year SHANGHAI SANYOU MEDICAL has showed a 24.50% decrease.
688085 net income for the last quarter is −2.10 M CNY, while the quarter before that showed 29.29 M CNY of net income which accounts for −107.15% change. Track more SHANGHAI SANYOU MEDICAL financial stats to get the full picture.
Today SHANGHAI SANYOU MEDICAL has the market capitalization of 4.67 B, it has increased by 4.29% over the last week.
Yes, 688085 dividends are paid annually. The last dividend per share was 0.09 CNY. As of today, Dividend Yield (TTM)% is 0.37%. Tracking SHANGHAI SANYOU MEDICAL dividends might help you take more informed decisions.
SHANGHAI SANYOU MEDICAL dividend yield was 0.40% in 2023, and payout ratio reached 20.28%. The year before the numbers were 0.28% and 9.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 688085 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI SANYOU MEDICAL stock right from TradingView charts — choose your broker and connect to your account.
688085 reached its all-time high on Jul 14, 2020 with the price of 74.30 CNY, and its all-time low was 11.97 CNY and was reached on Feb 5, 2024. View more price dynamics on 688085 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 3, 2024, the company has 466.00 employees. See our rating of the largest employees — is SHANGHAI SANYOU MEDICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI SANYOU MEDICAL technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI SANYOU MEDICAL stock shows the sell signal. See more of SHANGHAI SANYOU MEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.